The ESH 7th Translational Research Conference: Lymphoid Malignancies will address the rapidly evolving field of lymphoid malignancies, including T- and B-cell lymphomas, and chronic lymphocytic leukaemia (CLL), from molecular pathogenesis to state-of-the-art treatment and future perspectives. Chairs: Michael Hallek, Georg Lenz, Laurie Sehn, Louis Staudt

Date: Friday 20 - Sunday 22 October 2023
Venue: Estoril Congress Centre, Portugal

ESH Translational Research Conferences focus on leading-edge basic, clinical and therapeutic research and future perspectives. The presentation of unpublished data is encouraged. This leading-edge translational research conference will address the rapidly evolving field of lymphoid malignancies, including T- and B-cell lymphomas, and chronic lymphocytic leukaemia (CLL), from molecular pathogenesis to state-of-the-art treatment and future perspectives.

The goals of this conference are to:

  • foster scientific exchange between laboratory scientists and clinicians working on lymphoid malignancies worldwide
  • foster scientific cross-fertilisation between researchers and clinicians working on different diseases with partially overlapping pathogenic mechanisms such as the B cell receptor signaling, alterations of the DNA damage response, or the increasingly important dialogue of lymphoid tumour cells with their microenvironment
  • provide opportunities for leading-edge education and international networking to basic and clinical scientists, including those still in-training.

A first-class selection of international speakers will guarantee the highest quality of science and a summary of the most recent developments in the biology and therapy of lymphoid malignancies.

Continuing Medical Education (CME) credit points will be awarded to physicians for the time they will spend at the meeting improving their knowledge and skills. ESH is a provider of the European Haematology CME system.

Posters and Brief Oral Communications:

Registered participants are invited to submit their biology and clinical abstracts. Selected abstracts will be presented as brief oral communications or posters.

Call for abstracts: deadline 5 July 2023

This meeting will be valuable to you if you are looking for:

  • A cutting-edge scientific program – from basic science to clinical and therapeutic applications and perspectives
  • Multiple opportunities for scientific interaction with an international faculty of distinguished experts
  • An emphasis on critical discussion The meeting will provide clinicians and scientists with state-of-the-art recommendations regarding patient care and insight in controversies in the field.

The meeting will be of interest to:

  • Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)
  • Junior scientists and clinicians (MD, PhD) 
  • PhD candidates and clinical residents still in-training

Learning Objectives:

Improved understanding of :

  • current developments in the field of molecular pathogenesis of indolent and aggressive B-cell lymphoma including CLL
  • current developments in the field of the molecular pathogenesis of T-cell lymphoma
  • prognostic and predictive markers and their impact in specific clinical situations
  • current treatments and future therapeutic perspectives. Scientific

Topics:

  • Biology of diffuse large B cell lymphoma subtypes II
  • Novel molecular lymphoma subtypes
  • Epigenetic and genetic regulation of clonal lymphoma evolution
  • Lymphoma cell interactions in the tumor microenvironment
  • Monoclonal antibodies & non-cellular immune therapies
  • Cellular immune therapies
  • Small molecular pathway inhibitors
  • Combination therapies
  • Use of CT DNA for diagnostic and therapeutic monitoring

The programme will include:

  • Plenary Sessions
  • Simultaneous Meet the Experts Sessions
  • Round Table Discussions
  • Brief Oral Communications
  • Mentored Poster Walk
  • Ample time for in-depth discussion

Conference website and registration

External Events

Jun 25
5
6
24
25
Sep 25
26
29
Oct 25
2
10
16
June 5th 2025
Haematological Malignancy Diagnostic Service (H...
The Haematological Malignancy Diagnostic Service (HMDS) Integrated Diagnostic Course is a new innovative two-day cour...
Details
June 6th 2025
UK and Ireland MPN Educational Day...for MPN an...
The aim of this meeting is to bring together the UK and Ireland MPN nursing, pharmacy and AHP community for an educat...
Location: Cavendish Conference Centre
Details
June 24th 2025
What's New In Haematological Malignancies
An expert faculty will deliver a day of lectures and discussions to explore “What’s New in Haematological Malignancie...
Details
June 25th 2025
BSBMTCT Scientific Showcase: Advanced Cellular...
This event will highlight innovation in the field of cellular therapy and is aimed at all healthcare professionals wo...
Location: Cavendish Conference Centre
Details
September 26th 2025
ESH 3rd How I Manage: CAR-T Therapies and Bispe...
"The format of the meeting is based on the analysis and discussion of clinical case studies. It will adopt a problem-...
Details
September 29th 2025
Haematology in Obstetrics course 2025
The Haematology in Obstetrics course aims to develop an understanding of the physiology and pathology of obstetric ha...
Location: St Edmund Hall, Oxford University
Details
October 2nd 2025
ESH 8th Translational Research Conference: Lymp...
"The ESH 8th Translational Research Conference: Lymphoid Malignancies will address the rapidly evolving field of lymp...
Details
October 10th 2025
ESH-iCMLf 27th Annual John Goldman Conference o...
ESH-iCMLf 27th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy Chairs: Jorge Corte...
Details
October 16th 2025
ESH 7th International Conference: Acute Myeloid...
"The seventh bi-annual ESH conference in this series will offer discussions on the latest developments and emerging i...
Details